Healthcare Providers and Services
Company Overview of US Oncology, Inc.
US Oncology, Inc. operates a community-based cancer treatment and research network in the United States. Its network of doctors and practices focuses on cancer treatment and research. US Oncology, Inc. was formerly known as American Oncology Resources, Inc. and changed its name to US Oncology, Inc. in June 1999. The company was founded in 1992 and is headquartered in The Woodlands, Texas. US Oncology, Inc. operates as a subsidiary of McKesson Corporation.
10101 Woodloch Forest
The Woodlands, TX 77380
Founded in 1992
Key Executives for US Oncology, Inc.
Interim Chief Financial Officer
Chief Operating Officer and Executive Vice President
Chief Information Officer and Senior Vice President of Information & Technology Services
Chief Administration Officer and Executive Vice President
Compensation as of Fiscal Year 2014.
US Oncology, Inc. Key Developments
The US Oncology Network Appoints Kirk Kaminsky as President
Jun 9 14
McKesson Specialty Health and The US Oncology Network announced the appointment of Kirk Kaminsky as president, The US Oncology Network and Provider Services, effective immediately. In addition, Kirk Kaminsky was named president, The US Oncology Network and Provider Services, reporting to Nick. In this role, Kirk will be responsible for leading The US Oncology Network, its financial and operational support, and overall strategy in support of The US Oncology Network's vision of improving patient outcomes and quality of life. As senior vice president, McKesson Specialty Health Operations, Kirk successfully led multiple businesses serving community oncology practices, including the Onmark Select Program, group purchasing organizations and distribution services across brand, generics and oral oncolytics. He will continue to reside in The Woodlands, Texas.
McKesson Specialty Health and the US Oncology Network Appoint Jeffrey Kao as Chief Information Officer and Senior Vice President, Information & Technology Services
Jan 6 14
McKesson Specialty Health and The US Oncology Network announced the appointment of Jeffrey Kao as chief information officer and senior vice president, Information & Technology Services. As chief information officer and senior vice president, Information & Technology Services, Jeff will be responsible for overseeing all support technologies for practices in The US Oncology Network, overseeing the internal technology infrastructure and delivering innovative, advanced technology solutions to support the many physicians and customers that McKesson Specialty Health serves. Until recently, Jeff served as senior vice president and chief information officer for Coventry Health Care, Inc.
National Comprehensive Cancer Network, McKesson Specialty Health, and the US Oncology Network Announce Plans for Integration with Elekta and Varian
Sep 24 13
National Comprehensive Cancer Network, The US Oncology Network, and McKesson Specialty Health are pleased to announce agreements to provide future integration with Elekta and Varian that will enhance the ability to provide cancer patients with evidence-based quality care. By integrating with two leading oncology information systems -- Elekta's MOSAIQ(R) and Varian's Aria(R) -- the power of Clear Value Plus will be improved for practices using those platforms. Value Pathways Powered by NCCN, which are incorporated into the Clear Value Plus software, will expand next year to include radiation oncology. These clinical practice guidelines are jointly developed by McKesson Specialty Health, The US Oncology Network, and NCCN to consider efficacy and cost when evaluating treatment options in radiation oncology, building upon the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R)) and The US Oncology Network's Level I Pathways. Clear Value Plus, a first-of-its-kind clinical quality and regimen support system, allows physicians to access transparent, evidence-based clinical content at the point of care. It is fully embedded into McKesson Specialty Health's iKnowMed Generation 2SM EHR and will be integrated with MOSAIQ and Aria. The agreements to integrate the Elekta and Varian oncology information systems with the Clear Value Plus platform in an open, standards-based integration of technology will provide physicians with access to quality support and reporting solutions, as well as Value Pathways treatment options. Through Value Pathways, physicians can gain access to national best practices for optimal patient care and value-based outcomes that are grounded in clinical evidence and the NCCN Guidelines(R).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|